Skip to main content
Top
Published in: AIDS and Behavior 6/2014

Open Access 01-06-2014 | Substantive Review

Prevalence and Public Health Implications of State Laws that Criminalize Potential HIV Exposure in the United States

Authors: J. Stan Lehman, Meredith H. Carr, Allison J. Nichol, Alberto Ruisanchez, David W. Knight, Anne E. Langford, Simone C. Gray, Jonathan H. Mermin

Published in: AIDS and Behavior | Issue 6/2014

Login to get access

Abstract

For the past three decades, legislative approaches to prevent HIV transmission have been used at the national, state, and local levels. One punitive legislative approach has been enactment of laws that criminalize behaviors associated with HIV exposure (HIV-specific criminal laws). In the USA, HIV-specific criminal laws have largely been shaped by state laws. These laws impose criminal penalties on persons who know they have HIV and subsequently engage in certain behaviors, most commonly sexual activity without prior disclosure of HIV-positive serostatus. These laws have been subject to intense public debate. Using public health law research methods, data from the legal database WestlawNext© were analyzed to describe the prevalence and characteristics of laws that criminalize potential HIV exposure in the 50 states (plus the District of Columbia) and to examine the implications of these laws for public health practice. The first state laws were enacted in 1986; as of 2011 a total of 67 laws had been enacted in 33 states. By 1995, nearly two-thirds of all laws had been enacted; by 2000, 85 % of laws had been enacted; and since 2000, an additional 10 laws have been enacted. Twenty-four states require persons who are aware that they have HIV to disclose their status to sexual partners and 14 states require disclosure to needle-sharing partners. Twenty-five states criminalize one or more behaviors that pose a low or negligible risk for HIV transmission. Nearly two-thirds of states in the USA have legislation that criminalizes potential HIV exposure. Many of these laws criminalize behaviors that pose low or negligible risk for HIV transmission. The majority of laws were passed before studies showed that antiretroviral therapy (ART) reduces HIV transmission risk and most laws do not account for HIV prevention measures that reduce transmission risk, such as condom use, ART, or pre-exposure prophylaxis. States with HIV-specific criminal laws are encouraged to use the findings of this paper to re-examine those laws, assess the laws’ alignment with current evidence regarding HIV transmission risk, and consider whether the laws are the best vehicle to achieve their intended purposes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gable L, Gostin L, Hodge JG. A global assessment of the role of law in the HIV/AIDS pandemic. Public Health. 2009;123:260–4.PubMedCrossRef Gable L, Gostin L, Hodge JG. A global assessment of the role of law in the HIV/AIDS pandemic. Public Health. 2009;123:260–4.PubMedCrossRef
2.
go back to reference Lazzarini Z, Klitzman R. HIV and the law: integrating law, policy and social epidemiology. J Law Med Ethics. 2002;30(4):533–47.PubMedCrossRef Lazzarini Z, Klitzman R. HIV and the law: integrating law, policy and social epidemiology. J Law Med Ethics. 2002;30(4):533–47.PubMedCrossRef
3.
go back to reference Neff S, Goldschmidt R. Centers for Disease Control and Prevention 2006 human immunodeficiency virus testing recommendations and state testing laws. JAMA. 2011;305(17):1767–8.PubMedCrossRef Neff S, Goldschmidt R. Centers for Disease Control and Prevention 2006 human immunodeficiency virus testing recommendations and state testing laws. JAMA. 2011;305(17):1767–8.PubMedCrossRef
6.
go back to reference O’Toole EM. HIV-specific crime legislation: targeting an epidemic for criminal prosecution. J L Health. 1995–1996;10:183–208. O’Toole EM. HIV-specific crime legislation: targeting an epidemic for criminal prosecution. J L Health. 1995–1996;10:183–208.
7.
go back to reference Wolf LE, Vezina R. Crime and punishment: is there a role for criminal law in HIV prevention policy? Whittier L. Rev. 2004;25:821–86. Wolf LE, Vezina R. Crime and punishment: is there a role for criminal law in HIV prevention policy? Whittier L. Rev. 2004;25:821–86.
8.
go back to reference Lazzarini Z, Bray S, Burris S. Evaluating the impact of criminal laws on HIV risk behavior. J Law Med Ethics. 2002;30(2):239–53.PubMedCrossRef Lazzarini Z, Bray S, Burris S. Evaluating the impact of criminal laws on HIV risk behavior. J Law Med Ethics. 2002;30(2):239–53.PubMedCrossRef
9.
go back to reference Burris S, Cameron E. The case against criminalization of HIV transmission. JAMA. 2008;300(5):578–81.PubMedCrossRef Burris S, Cameron E. The case against criminalization of HIV transmission. JAMA. 2008;300(5):578–81.PubMedCrossRef
14.
go back to reference Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS Behav. 2006;10:451–61.PubMedCrossRef Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS Behav. 2006;10:451–61.PubMedCrossRef
15.
go back to reference Burris S, Beletsky L, Burleson J, Case P, Lazzarini Z. Do criminal laws influence HIV risk behavior? An empirical trial. Ariz St L J. 2007;39:467–517. Burris S, Beletsky L, Burleson J, Case P, Lazzarini Z. Do criminal laws influence HIV risk behavior? An empirical trial. Ariz St L J. 2007;39:467–517.
20.
go back to reference Galletly CL, Glasman LR, Pinkerton SD, DiFranceisco W. New Jersey’s HIV exposure law and HIV-related attitudes, beliefs, and sexual and seropositive status disclosure behaviors of persons living with HIV. Am J Public Health. 2012;102(11):2135–40.PubMedCrossRef Galletly CL, Glasman LR, Pinkerton SD, DiFranceisco W. New Jersey’s HIV exposure law and HIV-related attitudes, beliefs, and sexual and seropositive status disclosure behaviors of persons living with HIV. Am J Public Health. 2012;102(11):2135–40.PubMedCrossRef
21.
go back to reference Horvath KJ, Weinmeyer R, Rosser S. Should it be illegal for HIV-positive persons to have unprotected sex without disclosure? An examination of attitudes among US men who have sex with men and the impact of state law. AIDS Care. 2010;22(10):1221–8.PubMedCentralPubMedCrossRef Horvath KJ, Weinmeyer R, Rosser S. Should it be illegal for HIV-positive persons to have unprotected sex without disclosure? An examination of attitudes among US men who have sex with men and the impact of state law. AIDS Care. 2010;22(10):1221–8.PubMedCentralPubMedCrossRef
22.
go back to reference Galletly CL, Pinkerton SD. Preventing HIV transmission via HIV exposure laws: applying logic and mathematical modeling to compare statutory approaches to penalizing undisclosed exposure to HIV. J Law Med Ethics. 2008;36:577–84.PubMedCentralPubMedCrossRef Galletly CL, Pinkerton SD. Preventing HIV transmission via HIV exposure laws: applying logic and mathematical modeling to compare statutory approaches to penalizing undisclosed exposure to HIV. J Law Med Ethics. 2008;36:577–84.PubMedCentralPubMedCrossRef
23.
go back to reference Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR. 2008;57 (No. RR-9):1–83. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR. 2008;57 (No. RR-9):1–83.
25.
go back to reference Burris S, Wagenaar AC, Swanson J, Ibraham JK, Wood J, Mello MM. Making the case for laws that improve health: a framework for public health law research. Milbank Q. 2010;88(2):169–210.PubMedCentralPubMedCrossRef Burris S, Wagenaar AC, Swanson J, Ibraham JK, Wood J, Mello MM. Making the case for laws that improve health: a framework for public health law research. Milbank Q. 2010;88(2):169–210.PubMedCentralPubMedCrossRef
26.
go back to reference Burris S, Anderson E. The challenges of quantitative public health law research. Am J Prev Med. 2010;39(1):99–101.PubMedCrossRef Burris S, Anderson E. The challenges of quantitative public health law research. Am J Prev Med. 2010;39(1):99–101.PubMedCrossRef
27.
go back to reference Tremper C, Thomas S, Wagenaar AC. Measuring law for evaluation research. Evaluation Rev. 2010;34(3):242–66.CrossRef Tremper C, Thomas S, Wagenaar AC. Measuring law for evaluation research. Evaluation Rev. 2010;34(3):242–66.CrossRef
29.
go back to reference Centers for Disease Control and Prevention. HIV Surveillance-United States, 1981–2008. MMWR. 2011;60(21):689–93. Centers for Disease Control and Prevention. HIV Surveillance-United States, 1981–2008. MMWR. 2011;60(21):689–93.
31.
go back to reference Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochran DB Syst Rev. Wiley and Sons, 2012. Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochran DB Syst Rev. Wiley and Sons, 2012.
32.
33.
35.
go back to reference Hecht FM, Chesney MA, Lehman JS, et al. Does HIV reporting by name deter testing? AIDS. 2000;14(12):1801–8.PubMedCrossRef Hecht FM, Chesney MA, Lehman JS, et al. Does HIV reporting by name deter testing? AIDS. 2000;14(12):1801–8.PubMedCrossRef
36.
go back to reference Galletly CL, Pinkerton SD, DiFranceisco W. A quantitative study of Michigan’s criminal HIV exposure law. AIDS Care. 2012;24(2):174–9.PubMedCentralPubMed Galletly CL, Pinkerton SD, DiFranceisco W. A quantitative study of Michigan’s criminal HIV exposure law. AIDS Care. 2012;24(2):174–9.PubMedCentralPubMed
37.
go back to reference Gostin LO, Hodge JG. Piercing the veil of secrecy in HIV/AIDS and other sexually transmitted diseases: theories of privacy and disclosure in partner notification. Duke J Gender L Pol’y. 1998;5(9):9–88. Gostin LO, Hodge JG. Piercing the veil of secrecy in HIV/AIDS and other sexually transmitted diseases: theories of privacy and disclosure in partner notification. Duke J Gender L Pol’y. 1998;5(9):9–88.
Metadata
Title
Prevalence and Public Health Implications of State Laws that Criminalize Potential HIV Exposure in the United States
Authors
J. Stan Lehman
Meredith H. Carr
Allison J. Nichol
Alberto Ruisanchez
David W. Knight
Anne E. Langford
Simone C. Gray
Jonathan H. Mermin
Publication date
01-06-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0724-0

Other articles of this Issue 6/2014

AIDS and Behavior 6/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.